Skip to Main Content

Advertisement

Skip Nav Destination

Abstract A271: TAS-120, an irreversible FGFR inhibitor, was effective in tumors harboring FGFR mutations, refractory or resistant to ATP competitive inhibitors .

Mol Cancer Ther (2013) 12 (11_Supplement): A271.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Subhasmita Mahapatra
  • Nisha Amarnath Jonniya
  • Suman Koirala
  • Kapil Dattatray Ursal
  • Parimal Kar
Journal of Biomolecular Structure and Dynamics (2023) 41 (22): 13509.
  • Massimiliano Salati
  • Francesco Caputo
  • Cinzia Baldessari
  • Pietro Carotenuto
  • Marco Messina
  • Stefania Caramaschi
  • Massimo Dominici
  • Luca Reggiani Bonetti
Cancer Management and Research (2021) Volume 13: 7747.
  • Meng-di Dai
  • Yue-liang Wang
  • Jun Fan
  • Yang Dai
  • Yin-chun Ji
  • Yi-ming Sun
  • Xia Peng
  • Lan-lan Li
  • Yu-ming Wang
  • Wen-hu Duan
  • Jian Ding
  • Jing Ai
Acta Pharmacologica Sinica (2021) 42 (9): 1498.
  • R. Bahleda
  • F. Meric-Bernstam
  • L. Goyal
  • B. Tran
  • Y. He
  • I. Yamamiya
  • K.A. Benhadji
  • I. Matos
  • H.-T. Arkenau
Annals of Oncology (2020) 31 (10): 1405.
  • Xiaojing Lin
  • Yuliana Yosaatmadja
  • Maria Kalyukina
  • Martin J. Middleditch
  • Zhen Zhang
  • Xiaoyun Lu
  • Ke Ding
  • Adam V. Patterson
  • Jeff B. Smaill
  • Christopher J. Squire
ACS Medicinal Chemistry Letters (2019) 10 (8): 1180.
  • Giuseppe Marseglia
  • Alessio Lodola
  • Marco Mor
  • Riccardo Castelli
Expert Opinion on Therapeutic Patents (2019) 29 (12): 965.
  • Wen-Jun Xue
  • Ming-Tao Li
  • Lin Chen
  • Li-Ping Sun
  • Yu-Yan Li
Future Medicinal Chemistry (2018) 10 (17): 2109.
  • Antonella De Luca
  • Daniela Frezzetti
  • Marianna Gallo
  • Nicola Normanno
Expert Opinion on Investigational Drugs (2017) 26 (3): 303.
  • Niamh Hallinan
  • Stephen Finn
  • Sinead Cuffe
  • Shereen Rafee
  • Kenneth O’Byrne
  • Kathy Gately
Cancer Treatment Reviews (2016) 46: 51.
Close Modal

or Create an Account

Close Modal
Close Modal